HDAC1
Histone deacetylase 1
Also known as: GON-10, HD1, HDAC1_HUMAN, KDAC1, RPD3L1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13547
- Gene
- HDAC1
- Ensembl
- ENSG00000116478
- Chromosome
- 1
- Canonical length
- 482 aa
- Protein class
- Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Histone acetylation and deacetylation, catalyzed by multisubunit complexes, play a key role in the regulation of eukaryotic gene expression. The protein encoded by this gene belongs to the histone deacetylase/acuc/apha family and is a component of the histone deacetylase complex. It also interacts with retinoblastoma tumor-suppressor protein and this complex is a key element in the control of cell proliferation and differentiation. Together with metastasis-associated protein-2, it deacetylates p53 and modulates its effect on cell growth and apoptosis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
482 residues, UniProt reviewed canonical sequence.
>Q13547|HDAC1
1 MAQTQGTRRK VCYYYDGDVG NYYYGQGHPM KPHRIRMTHN LLLNYGLYRK MEIYRPHKAN
61 AEEMTKYHSD DYIKFLRSIR PDNMSEYSKQ MQRFNVGEDC PVFDGLFEFC QLSTGGSVAS
121 AVKLNKQQTD IAVNWAGGLH HAKKSEASGF CYVNDIVLAI LELLKYHQRV LYIDIDIHHG
181 DGVEEAFYTT DRVMTVSFHK YGEYFPGTGD LRDIGAGKGK YYAVNYPLRD GIDDESYEAI
241 FKPVMSKVME MFQPSAVVLQ CGSDSLSGDR LGCFNLTIKG HAKCVEFVKS FNLPMLMLGG
301 GGYTIRNVAR CWTYETAVAL DTEIPNELPY NDYFEYFGPD FKLHISPSNM TNQNTNEYLE
361 KIKQRLFENL RMLPHAPGVQ MQAIPEDAIP EESGDEDEDD PDKRISICSS DKRIACEEEF
421 SDSEEEGEGG RKNSSNFKKA KRVKTEDEKE KDPEEKKEVT EEEKTKEEKP EAKGVKEEVK
481 LALocalizationUniProt · AlphaFold · HPA
Whether an antibody against HDAC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 116 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 116 nTPM
- colon: 112 nTPM
- lymph node: 112 nTPM
- rectum: 102 nTPM
- thymus: 97 nTPM
- stomach: 79 nTPM
Single-cell type
- esophageal apical cells: 183 nCPM
- esophageal suprabasal cells: 171 nCPM
- foveolar cells: 163 nCPM
- colonocytes: 158 nCPM
- extravillous trophoblasts: 150 nCPM
- goblet cells: 144 nCPM
Immune cell
- total PBMC: 205 nTPM
- eosinophil: 201 nTPM
- non-classical monocyte: 157 nTPM
- memory B-cell: 152 nTPM
- basophil: 148 nTPM
- NK-cell: 145 nTPM
Brain region
- medulla oblongata: 19 nTPM
- white matter: 18 nTPM
- thalamus: 17 nTPM
- hypothalamus: 16 nTPM
- basal ganglia: 16 nTPM
- cerebellum: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HDAC1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 63 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.61
- gnomAD missense Z
- 3.04
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to platelet-derived growth factor stimulus
- chromatin organization
- chromatin remodeling
- circadian regulation of gene expression
- DNA methylation-dependent constitutive heterochromatin formation
- embryonic digit morphogenesis
- endoderm development
- epidermal cell differentiation
- eyelid development in camera-type eye
- fungiform papilla formation
- hair follicle placode formation
- heterochromatin formation
- hippocampus development
- host-mediated suppression of viral transcription
- negative regulation of androgen receptor signaling pathway
- negative regulation of apoptotic process
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cell migration
- negative regulation of DNA-templated transcription
- negative regulation of gene expression
- negative regulation of gene expression, epigenetic
- negative regulation of intrinsic apoptotic signaling pathway
- negative regulation of stem cell population maintenance
- negative regulation of transcription by RNA polymerase II
- negative regulation of transforming growth factor beta receptor signaling pathway
- neuron differentiation
- odontogenesis of dentin-containing tooth
- oligodendrocyte differentiation
- positive regulation of cell population proliferation
- positive regulation of DNA-templated transcription
- positive regulation of gene expression
- positive regulation of intracellular estrogen receptor signaling pathway
- positive regulation of oligodendrocyte differentiation
- positive regulation of smooth muscle cell proliferation
- positive regulation of stem cell population maintenance
- positive regulation of transcription by RNA polymerase II
- regulation of cell fate specification
- regulation of stem cell differentiation
- regulation of transcription by RNA polymerase II
Molecular functions
- core promoter sequence-specific DNA binding
- DNA-binding transcription factor binding
- E-box binding
- enzyme binding
- histone deacetylase activity
- histone deacetylase activity, hydrolytic mechanism
- histone deacetylase binding
- histone decrotonylase activity
- Krueppel-associated box domain binding
- metal ion binding
- NF-kappaB binding
- p53 binding
- promoter-specific chromatin binding
- protein lysine deacetylase activity
- protein lysine delactylase activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II core promoter sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription corepressor activity
- transcription corepressor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HDAC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HDAC1 as an antibody target. Whether an autoantibody or antibody against HDAC1 could matter depends on whether native HDAC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HDAC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HDAC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...